Big Bets and Strategic Moves Drive Biotech Investment in 2025 12 months ago JohnIn InvestmentsLeadersPartnerships
Laquinimod Eye Drops Show Safety and Penetration in Phase I LION Trial 12 months ago JohnIn Clinical TrialsTop Stories
Emerging Clinical Research Highlights Innovation and Regulatory Progress 12 months ago JohnIn Clinical TrialsDeals
Phase II Trial of Novel Radiopharmaceutical NeoB-GRP Shows Early Promise in Prostate Cancer 12 months ago JohnIn Biopharma HighlightsTop Stories
TrialMatchAI Demonstrates Strong Patient-to-Trial Matching Capabilities for Oncology Studies 12 months ago JohnIn AI & DataClinical Trials
Vera Therapeutics and Minovia Push Forward in Clinical Development 12 months ago JohnIn Research UpdatesTop Stories
AC Immune and Edgewise Therapeutics Report Promising Clinical Progress 12 months ago JohnIn BreakthroughsClinical Trials
MAIA Biotechnology Sets Its Sights on Bold Cancer Immunotherapy Milestones for 2025 12 months ago JohnIn Breaking NewsFDA ApprovalsLeadersResearch UpdatesTop Stories
MaaT Pharma Presents Promising Preclinical Data for Next-Gen Microbiome Therapy MaaT034 at AACR 12 months ago JohnIn Biopharma HighlightsClinical TrialsFunding RoundsInnovation
Gene-Silencing Therapy Lepodisiran Shows Major Reduction in Lipoprotein(a); Spinogenix Opens Phase 2 Schizophrenia Trial 12 months ago JohnIn Biopharma HighlightsClinical TrialsInnovationResearch Updates
FDA Leadership Change Sparks Industry Concern as Pharma Navigates Regulatory Challenges 12 months ago JohnIn Biopharma HighlightsInnovationLeadersPharma Industry Updates
FDA Approves Fitusiran for Hemophilia A and B; Vertex Halts VX-264 Type 1 Diabetes Trial 12 months ago JohnIn Clinical TrialsFDA ApprovalsInnovationPharma Industry Updates
FDA Approves Fitusiran (Qfitlia) – First RNAi Therapeutic for Hemophilia A and B; Vertex Halts VX-264 T1D Trial 1 year ago JohnIn Clinical TrialsFDA ApprovalsInnovationPharma Industry Updates
MaaT Pharma Completes €13 Million Capital Increase; Highlights 2024 Progress and 2025 Growth Plans 1 year ago JohnIn Biopharma HighlightsClinical TrialsFunding RoundsInnovationPharma Industry Updates
Viking Therapeutics Reports Full Enrollment in Phase 2 Oral Obesity Drug Trial; Bluejay Therapeutics Advances in Neurological Research 1 year ago JohnIn Clinical TrialsInnovationPharma Industry UpdatesResearch Updates
